NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet declared a quarterly dividend on Monday, December 16th. Stockholders of record on Friday, December 27th will be given a dividend of $0.24 per share on Friday, January 31st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date is Thursday, December 26th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its quarterly earnings results on Tuesday, February, 4th. The medical equipment provider reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.27 by $0.03. The medical equipment provider had revenue of $2.13 billion for the quarter, compared to analyst estimates of $2.11 billion. Zimmer Biomet had a net margin of 14.18% and a return on equity of 13.64%. The business's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.18 EPS. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, April 24th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet issued an update on its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share guidance of $8.15 to $8.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.29. The company issued revenue guidance of $8.18 billion to $8.26 billion, compared to the consensus revenue estimate of $8.16 billion.

26 Wall Street analysts have issued twelve-month price objectives for Zimmer Biomet's stock. Their forecasts range from $121.71 to $190.00. On average, they expect Zimmer Biomet's share price to reach $161.76 in the next year. This suggests a possible upside of 10.4% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 3 hold ratings, 20 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

Media stories about ZBH stock have been trending somewhat negative this week, according to InfoTrie. The research firm rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Zimmer Biomet earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Align Technology (ALGN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX) and Invacare (IVC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Walt Disney (DIS), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Home Depot (HD), Visa (V), Intel (INTC) and Verizon Communications (VZ).

Zimmer Biomet's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (5.20%), State Street Corp (4.13%), Boston Partners (2.04%), Geode Capital Management LLC (1.56%), Amundi Pioneer Asset Management Inc. (1.25%) and Ceredex Value Advisors LLC (1.14%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Massachusetts Financial Services Co. MA, Man Group plc, Snow Capital Management LP, Panagora Asset Management Inc., Wedge Capital Management L L P NC, Cubist Systematic Strategies LLC and Ceredex Value Advisors LLC. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was acquired by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., FMR LLC, Alliancebernstein L.P., Boston Partners, UBS Asset Management Americas Inc., Anchor Capital Advisors LLC, State Street Corp and Alleghany Corp DE. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $146.56.

Zimmer Biomet has a market capitalization of $30.25 billion and generates $7.98 billion in revenue each year. The medical equipment provider earns $1.13 billion in net income (profit) each year or $7.87 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]